ZA200701016B - Process for the preparation of isothiazole derivatives - Google Patents

Process for the preparation of isothiazole derivatives

Info

Publication number
ZA200701016B
ZA200701016B ZA200701016A ZA200701016A ZA200701016B ZA 200701016 B ZA200701016 B ZA 200701016B ZA 200701016 A ZA200701016 A ZA 200701016A ZA 200701016 A ZA200701016 A ZA 200701016A ZA 200701016 B ZA200701016 B ZA 200701016B
Authority
ZA
South Africa
Prior art keywords
preparation
isothiazole derivatives
isothiazole
derivatives
Prior art date
Application number
ZA200701016A
Other languages
English (en)
Inventor
David B Damon
Brian P Jones
Original Assignee
Pfizer Prod Inc
Osi Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc, Osi Pharm Inc filed Critical Pfizer Prod Inc
Publication of ZA200701016B publication Critical patent/ZA200701016B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA200701016A 2004-08-26 2007-02-02 Process for the preparation of isothiazole derivatives ZA200701016B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60454204P 2004-08-26 2004-08-26

Publications (1)

Publication Number Publication Date
ZA200701016B true ZA200701016B (en) 2008-05-28

Family

ID=36000502

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200701016A ZA200701016B (en) 2004-08-26 2007-02-02 Process for the preparation of isothiazole derivatives

Country Status (22)

Country Link
US (2) US8884025B2 (pt)
EP (1) EP1784183B1 (pt)
JP (2) JP5100390B2 (pt)
KR (1) KR100893977B1 (pt)
CN (1) CN101043888B (pt)
AR (1) AR050613A1 (pt)
AT (1) ATE542533T1 (pt)
AU (1) AU2005280451B2 (pt)
BR (1) BRPI0514667A (pt)
CA (1) CA2578023C (pt)
DK (1) DK1784183T3 (pt)
ES (1) ES2378994T3 (pt)
HK (1) HK1111359A1 (pt)
IL (1) IL181063A0 (pt)
MX (1) MX2007002246A (pt)
NO (1) NO20071319L (pt)
PL (1) PL1784183T3 (pt)
PT (1) PT1784183E (pt)
RU (1) RU2349588C2 (pt)
TW (1) TWI361688B (pt)
WO (1) WO2006026034A2 (pt)
ZA (1) ZA200701016B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1784183B1 (en) 2004-08-26 2012-01-25 Pfizer Inc. Processes for the preparation of isothiazole derivatives
ES2851602T3 (es) 2011-12-28 2021-09-08 Allergan Inc Derivados de 3-fenil-5-ureidoisotiazol-4-carboxamida como inhibidores de cinasa
CN103833665B (zh) * 2014-02-24 2015-09-23 杰达维(上海)医药科技发展有限公司 一种新的合成异噻唑的方法
US9353093B2 (en) 2014-10-07 2016-05-31 Allergan, Inc. Indole-1-carboxamides as kinase inhibitors
US9403803B2 (en) 2014-10-08 2016-08-02 Allergan, Inc. Indole-3-carboxamides as kinase inhibitors
US9359336B2 (en) 2014-10-09 2016-06-07 Allergan, Inc. Heterocycle-substituted pyridyl benzothiophenes as kinase inhibitors
US9371314B2 (en) 2014-10-09 2016-06-21 Allergan, Inc. Pyridyl benzothiophenes as kinase inhibitors
WO2024140850A1 (zh) * 2022-12-28 2024-07-04 苏州必扬医药科技有限公司 一种蛋白酪氨酸激酶抑制剂及其医药用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2408234A1 (de) * 1974-02-21 1975-09-04 Celamerck Gmbh & Co Kg Isothiazolylharnstoffe
US4059433A (en) * 1976-06-18 1977-11-22 Fmc Corporation 3-Alkoxyisothiazole derivatives as herbicides
IL72093A0 (en) * 1983-06-20 1984-10-31 Lilly Co Eli N'-substituted(3-alkyl-5-isothiazolyl)urea derivatives
UA60365C2 (uk) * 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
HN2000000051A (es) * 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
MXPA05000950A (es) * 2002-07-25 2005-05-16 Pfizer Prod Inc Derivados de isotiazol utiles como agentes anticancerosos.
US20060035954A1 (en) * 2004-08-11 2006-02-16 Sharma Padam N Ammonolysis process for the preparation of intermediates for DPP IV inhibitors
EP1784183B1 (en) 2004-08-26 2012-01-25 Pfizer Inc. Processes for the preparation of isothiazole derivatives

Also Published As

Publication number Publication date
ES2378994T3 (es) 2012-04-19
BRPI0514667A (pt) 2008-06-17
CN101043888A (zh) 2007-09-26
JP2008510841A (ja) 2008-04-10
JP5498524B2 (ja) 2014-05-21
NO20071319L (no) 2007-05-29
WO2006026034A2 (en) 2006-03-09
HK1111359A1 (en) 2008-08-08
EP1784183A4 (en) 2009-12-09
TWI361688B (en) 2012-04-11
CN101043888B (zh) 2010-08-11
CA2578023A1 (en) 2006-03-09
AR050613A1 (es) 2006-11-08
KR100893977B1 (ko) 2009-04-20
DK1784183T3 (da) 2012-04-02
US9371298B2 (en) 2016-06-21
RU2349588C2 (ru) 2009-03-20
JP2012153705A (ja) 2012-08-16
AU2005280451A1 (en) 2006-03-09
IL181063A0 (en) 2007-07-04
KR20070070158A (ko) 2007-07-03
PT1784183E (pt) 2012-03-09
TW200621241A (en) 2006-07-01
EP1784183B1 (en) 2012-01-25
US20090023924A1 (en) 2009-01-22
US8884025B2 (en) 2014-11-11
CA2578023C (en) 2012-05-15
US20150065726A1 (en) 2015-03-05
EP1784183A2 (en) 2007-05-16
PL1784183T3 (pl) 2012-07-31
ATE542533T1 (de) 2012-02-15
WO2006026034A3 (en) 2006-06-29
JP5100390B2 (ja) 2012-12-19
RU2007106847A (ru) 2008-08-27
AU2005280451B2 (en) 2009-02-05
MX2007002246A (es) 2007-04-20

Similar Documents

Publication Publication Date Title
IL187458A0 (en) Process for preparation of sulfamide derivatives
IL198847A0 (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives
IL190135A0 (en) Process for the preparation of pyrimidinedione derivatives
IL194522A0 (en) Process for the preparation of prasugrel
EP1893625A4 (en) PROCESS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES
ZA200804264B (en) Process for the preparation of ferri-succinylcasein
ZA200710914B (en) Process for the preparation of sulfonamide derivatives
ZA200701016B (en) Process for the preparation of isothiazole derivatives
PT1737820E (pt) Processo de hidrogenação assimétrica útil para a preparação de derivados de cicloalcanoindole
ZA200601910B (en) Process for the preparation of organosilances
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
GB2436262B (en) Process for the preparation of pantoprazole sodium
IL178539A0 (en) Process for preparation of probucol derivatives
PL1937662T3 (pl) Sposób wytwarzania duloksetyny
PL1928883T3 (pl) Sposób otrzymywania chlorowodorku irynotekanu
HU0401379D0 (en) Process for the preparation of risperidon
IL178960A0 (en) Process for the preparation of pyridin-2-ylmethylsulphinyl-1h-benzimidazol compounds
EP1797056A4 (en) PROCESS FOR THE PREPARATION OF GLYCIDYL DERIVATIVES
IL186457A0 (en) Process for the preparation of 9,10-dehydro-12,13-desoxyepothilone derivatives
IL177353A0 (en) Process for the preparation of aq4n
IL178237A0 (en) Process for the preparation of rosiglitazone
ZA200706203B (en) Processes and compounds for the preparation of substituted naphthylindole derivatives
HUP0501046A2 (en) Process for the preparation of olanzapine
HUP0500570A3 (en) Process for the preparation of (s)-(-)-amlodipine
SI1732916T1 (sl) Postopek za pripravo alkoksikarbonilmetoksi-ciklopentanov